EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,000 | -86.0% | 1,903 | -75.4% | 0.00% | -100.0% |
| Q2 2022 | $50,000 | +78.6% | 7,735 | +1005.0% | 0.00% | +200.0% |
| Q1 2022 | $28,000 | +250.0% | 700 | +250.0% | 0.00% | – |
| Q4 2021 | $8,000 | -74.2% | 200 | -60.0% | 0.00% | -100.0% |
| Q2 2021 | $31,000 | -16.2% | 500 | +25.0% | 0.00% | -50.0% |
| Q1 2021 | $37,000 | -65.4% | 400 | -81.9% | 0.00% | -60.0% |
| Q4 2020 | $107,000 | +161.0% | 2,210 | +452.5% | 0.01% | +66.7% |
| Q3 2020 | $41,000 | – | 400 | +300.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 100 | -98.1% | 0.00% | – |
| Q4 2016 | $11,000 | -72.5% | 5,300 | -74.0% | 0.00% | -100.0% |
| Q3 2016 | $40,000 | -74.7% | 20,400 | -39.1% | 0.00% | -88.9% |
| Q2 2016 | $158,000 | – | 33,500 | +6600.0% | 0.01% | – |
| Q1 2016 | $0 | -100.0% | 500 | +150.0% | 0.00% | – |
| Q4 2015 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,080,519 | $44,336,000 | 4.65% |
| GREAT POINT PARTNERS LLC | 290,000 | $6,180,000 | 2.65% |
| FIDUCIARY MANAGEMENT ASSOCIATES LLC | 651,884 | $13,892,000 | 0.99% |
| Matarin Capital Management, LLC | 85,003 | $1,811,414,000 | 0.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 407,000 | $8,673,000 | 0.39% |
| ICON ADVISERS INC/CO | 258,478 | $5,508,000 | 0.32% |
| RMB Capital Management, LLC | 178,204 | $3,798,000 | 0.23% |
| NEW AMSTERDAM PARTNERS LLC/NY | 159,470 | $3,398,000 | 0.23% |
| GLOBEFLEX CAPITAL L P | 94,016 | $2,003,000 | 0.23% |
| Convergence Investment Partners, LLC | 58,672 | $1,250,000 | 0.17% |